Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of a Clinically Feasible Molecular Assay to Predict Recurrence of Stage II Colon Cancer

14 Jun 2008

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Surgical Treatments
Share to Colorectal Cancer Treatments and Studies
Share to Genetic factors in colorectal cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 18556775
DOI: 10.2353/jmoldx.2008.080011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of a Clinically Feasible Molecular Assay to Predict Recurrence of Stage II Colon CancerPMID 18556775Read ↗

Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: Current updatesSemantic proximity Read ↗

Application of molecular techniques in the diagnosis, prognosis and management of patients with colorectal cancer: a practical approachSemantic proximity Read ↗

[II. Clinical Guidelines of Molecular Testing for Colorectal Cancer].Semantic proximity Read ↗

Biomarker Profile of Colorectal Cancer: Current Findings and Future PerspectiveSemantic proximity Read ↗

[Examination of molecular markers used n the treatment of colon cancer].Semantic proximity Read ↗

Biomarker-based prediction of response to therapy for colorectal cancer: current perspective.Semantic proximity Read ↗

Recent advances in personalized colorectal cancer research.Semantic proximity Read ↗

Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.Semantic proximity Read ↗

Recent advances in the molecular diagnosis and prognosis of colorectal cancer.Semantic proximity Read ↗

A novel epigenetic signature to predict recurrence-free survival in patients with colon cancerSemantic proximity Read ↗

Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal CancerSemantic proximity Read ↗

Recent developments in molecular biology, screening, and treatment of colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.